The Square-backed event ticketing technology provider will float at the top of its range having previously raised almost $360m in equity funding.

Biocon, which owns nearly a fifth in the company thanks to a licensing agreement, is in line for an exit when Equillium lists on the Nasdaq Global Market.

Tencent and Xiaomi-backed news aggregation platform Qutoutiao floated at the foot of its range, in an IPO in which JD.com invested about $14m.

The immuno-oncology therapy developer's investors include Pfizer and Gilead Sciences, both of which contributed to a $300m round in January.

The GSK-backed small molecule drug developer floated at the top of its range to raise just over $106m.

The connected planning software provider has raised a total of $300m from investors including Salesforce and Workday and was valued at $1.4bn in 2017.

Rocket Internet-backed online furniture retailer Westwing aims to raise $139m in an initial public offering in Frankfurt.

The Tencent, Baidu, Lenovo and JD.com-backed electric carmaker floated near the foot of its range at a reported $6.4bn valuation.

The Tencent-backed local services portal has priced the offering near the top of its range at a valuation of about $52bn.

Guardant Health is targeting $100m in proceeds for its initial public offering on the Nasdaq Global Select Market, which would offer an exit to SoftBank.